Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M » 08:39
09/29/22
09/29
08:39
09/29/22
08:39
TTOO

T2 Biosystems

/

+

T2 Biosystems announced…

T2 Biosystems announced that the Biomedical Advanced Research and Development Authority, BARDA, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing an additional $3.7M in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems. The total potential BARDA funding if all contract options are exercised is $62M, reflecting a reduction in the scope of work under contract option 3. The additional funding will be used to advance the U.S. clinical trials for the T2Resistance Panel and T2Biothreat Panel and file submissions to the U.S. Food and Drug Administration for U.S. regulatory clearance. "We are pleased to advance the U.S. clinical trials for the T2Resistance Panel and T2Biothreat Panel, in collaboration with BARDA, and subsequently file submissions with FDA for U.S. regulatory clearance," stated John Sperzel, Chairman and CEO of T2 Biosystems. "These new products will expand the test menu on our T2Dx Instrument and have the potential to reduce the threat of antimicrobial resistance and protect the nation from biothreat pathogens."

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Over a week ago
Hot Stocks
T2 Biosystems announces commercial expansion though distributor in Baltic Region » 16:20
09/22/22
09/22
16:20
09/22/22
16:20
TTOO

T2 Biosystems

/

+

T2 Biosystems announced…

T2 Biosystems announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through the distributor. The execution of this exclusive distribution agreement further expands T2 Biosystems' commercialization. Epidemiology studies have shown that the Baltic region has a higher average incidence of sepsis per population than Western Europe.1 There have been national guidelines in the region to address the impact of sepsis.2 The introduction of the T2Dx Instrument and sepsis panels into these countries will allow rapid detection of sepsis-causing pathogens and antibiotic resistance genes, in hours instead of days, enabling clinicians to achieve targeted therapy, faster.

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Over a month ago
Hot Stocks
T2 Biosystems seeks shareholder approval for reverse stock split » 07:51
08/16/22
08/16
07:51
08/16/22
07:51
TTOO

T2 Biosystems

/

+

In a regulatory filing,…

In a regulatory filing, T2 Biosystems gave notice that its 2022 annual meeting of stockholders will be held on Tuesday, October 11, at which the company will ask shareholders to approve an amendment to the company's restated certificate of incorporation to effect a reverse stock split of the company's common stock at a reverse split ratio ranging from any whole number between and including 1-for-10 and 1-for-50, with the exact ratio within such range to be determined at the discretion of the board, subject to the board of directors' authority to abandon the amendment.

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Earnings
T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year » 16:15
08/15/22
08/15
16:15
08/15/22
16:15
TTOO

T2 Biosystems

/

+

Reports Q2 revenue…

Reports Q2 revenue $5.91M, consensus $6.13M. "Our second quarter results demonstrate continued execution across our three corporate priorities: accelerating our sales, enhancing our operations, and advancing our pipeline," stated John Sperzel, chairman and CEO of T2 Biosystems. "While we have seen an expected decline in sales of COVID-19 tests, we are pleased with our continued progress driving adoption of our T2Dx Instrument and sepsis test panels, while improving operating efficiency and advancing the U.S. clinical trials for the T2Resistance Panel and the T2Biothreat Panel. We strengthened our balance sheet during and subsequent to the end of the second quarter, allowing us to achieve our near-term milestones and keeping us well positioned to drive sustainable, long-term growth."

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Hot Stocks
T2 Biosystems to explore potential to develop test for Monkeypox virus » 08:39
08/09/22
08/09
08:39
08/09/22
08:39
TTOO

T2 Biosystems

/

+

T2 Biosystems announced…

T2 Biosystems announced plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility. "Our team has demonstrated the scientific expertise to develop new tests on our proprietary platform, including direct-from-blood and swab tests, and we believe the development of a molecular diagnostic test for the monkeypox virus is possible on our platform," stated John Sperzel, Chairman and CEO of T2Biosystems. "Given the urgent nature of the monkeypox virus, and the potential for global transmission, we have communicated with the FDA and CDC and we are exploring the potential to develop and commercialize a test for the monkeypox virus."

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Hot Stocks
T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel » 08:06
07/11/22
07/11
08:06
07/11/22
08:06
TTOO

T2 Biosystems

/

+

T2 Biosystems announced…

T2 Biosystems announced the U.S. Food and Drug Administration has granted Breakthrough Device Designation for the Company's T2Lyme Panel. The T2Lyme Panel is a direct-from-blood molecular diagnostic test designed to run on the FDA-cleared T2Dx Instrument and simultaneously detect the bacteria that cause Lyme disease: Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. The T2Lyme Panel is intended to test individuals with signs and symptoms of Lyme disease and aid in the diagnosis of early Lyme disease.

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Downgrade
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners » 08:49
07/07/22
07/07
08:49
07/07/22
08:49
TTOO

T2 Biosystems

$0.16 /

-0.03 (-15.87%)

Alliance Global Partners…

Alliance Global Partners analyst Ben Haynor downgraded T2 Biosystems to Neutral from Buy with a price target of $0.14, down from $0.65, after the company announced a preliminary Q2 revenue miss. Based on preliminary results, he is reducing his 2022 and 2023 revenue estimates and notes that T2 now has less than two quarters of cash remaining. He does not expect to see investors move off the sidelines into the shares given its situation and the presently difficult market conditions, Haynor said.

ShowHide Related Items >><<
TTOO T2 Biosystems
$0.16 /

-0.03 (-15.87%)

TTOO T2 Biosystems
$0.16 /

-0.03 (-15.87%)

07/07/22 BTIG
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
02/18/22 Canaccord
T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord
TTOO T2 Biosystems
$0.16 /

-0.03 (-15.87%)

TTOO T2 Biosystems
$0.16 /

-0.03 (-15.87%)

Downgrade
T2 Biosystems downgraded on 'broad-based' shortfall at BTIG » 07:24
07/07/22
07/07
07:24
07/07/22
07:24
TTOO

T2 Biosystems

/

+

BTIG analyst Mark Massaro…

BTIG analyst Mark Massaro downgraded T2 Biosystems to Neutral from Buy without a price target after the company preannounced a Q2 shortfall. Management said the timing of system orders was one factor, but indicated they were also below their expectations on sepsis and COVID testing, which means the shortfall was broad-based, Massaro tells investors in a research note. T2 will need 56% of contribution in the back half of the year on revenue to meet guidance, a heavier weighting versus last year's 51% back-half weighting, which may prove to be challenging, says the analyst. Massaro awaits greater clarity on T2's back half operations, which he says will include updates related to financing as well as a potential remedy for a Nasdaq delisting.

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

07/07/22 BTIG
T2 Biosystems downgraded to Neutral from Buy at BTIG
02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
02/18/22 Canaccord
T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord
01/18/22 Canaccord
T2 Biosystems significantly undervalued at current levels, say Canaccord
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

Downgrade
T2 Biosystems downgraded to Neutral from Buy at BTIG » 06:43
07/07/22
07/07
06:43
07/07/22
06:43
TTOO

T2 Biosystems

/

+

BTIG analyst Mark Massaro…

BTIG analyst Mark Massaro downgraded T2 Biosystems to Neutral from Buy.

ShowHide Related Items >><<
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
02/18/22 Canaccord
T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord
01/18/22 Canaccord
T2 Biosystems significantly undervalued at current levels, say Canaccord
TTOO T2 Biosystems
/

+

TTOO T2 Biosystems
/

+

On The Fly
What You Missed On Wall Street On Wednesday » 16:12
07/06/22
07/06
16:12
07/06/22
16:12
AMZN

Amazon.com

$114.19 /

+0.635 (+0.56%)

, TKAYY

Just Eat Takeaway.com

$10.47 /

+ (+0.00%)

, MSFT

Microsoft

$265.97 /

+3.1 (+1.18%)

, ATVI

Activision Blizzard

$78.32 /

-0.505 (-0.64%)

, MO

Altria Group

$41.09 /

-0.625 (-1.50%)

, RFP

Resolute Forest

$20.34 /

+7.85 (+62.85%)

, $ECON

Economic Data

/

+

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$382.99 /

+1.02 (+0.27%)

, RKT

Rocket Companies

$8.38 /

+0.32 (+3.97%)

, RNG

RingCentral

$55.37 /

-5.86 (-9.57%)

, COIN

Coinbase

$51.76 /

-3.625 (-6.55%)

, ENTA

Enanta

$51.26 /

-1.54 (-2.92%)

, UHS

Universal Health

$102.27 /

-2.59 (-2.47%)

, HCA

HCA Healthcare

$166.48 /

-6.04 (-3.50%)

, MAR

Marriott

$135.50 /

-3.21 (-2.31%)

, VIVHY

Vivendi

$9.47 /

-0.06 (-0.63%)

, LGF.A

Lionsgate

$8.35 /

-0.365 (-4.19%)

, LGF.B

Lionsgate

$7.93 /

-0.295 (-3.59%)

, CWK

Cushman & Wakefield

$14.84 /

-0.91 (-5.78%)

, PINC

Premier

$37.00 /

+1.21 (+3.38%)

, PTON

Peloton

$10.14 /

-0.27 (-2.59%)

, VERU

Veru

$13.02 /

+1.51 (+13.12%)

, RIVN

Rivian Automotive

$29.61 /

+2.74 (+10.20%)

, TLRY

Tilray

$3.49 /

+0.265 (+8.22%)

, WISH

ContextLogic

$1.63 /

-0.15 (-8.45%)

, DASH

DoorDash

$69.19 /

-5.7 (-7.61%)

, UBER

Uber

$21.44 /

-1.09 (-4.84%)

, KRNT

Kornit Digital

$23.24 /

-8.31 (-26.34%)

, RADA

Rada Electronic

$7.70 /

-1.33 (-14.73%)

, TTOO

T2 Biosystems

/

+

, ARTW

Art's Way

$2.35 /

-0.46 (-16.37%)

, SFET

Safe-T

/

+

Get caught up quickly on…

ShowHide Related Items >><<
WISH ContextLogic
$1.63 /

-0.15 (-8.45%)

VERU Veru
$13.02 /

+1.51 (+13.12%)

UHS Universal Health
$102.27 /

-2.59 (-2.47%)

UBER Uber
$21.44 /

-1.09 (-4.84%)

TTOO T2 Biosystems
/

+

TLRY Tilray
$3.49 /

+0.265 (+8.22%)

TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

SPX S&P 500
/

+

SFET Safe-T
/

+

RNG RingCentral
$55.37 /

-5.86 (-9.57%)

RKT Rocket Companies
$8.38 /

+0.32 (+3.97%)

RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

RFP Resolute Forest
$20.34 /

+7.85 (+62.85%)

RADA Rada Electronic
$7.70 /

-1.33 (-14.73%)

PTON Peloton
$10.14 /

-0.27 (-2.59%)

PINC Premier
$37.00 /

+1.21 (+3.38%)

MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

MO Altria Group
$41.09 /

-0.625 (-1.50%)

MAR Marriott
$135.50 /

-3.21 (-2.31%)

LGF.A Lionsgate
$8.35 /

-0.365 (-4.19%)

KRNT Kornit Digital
$23.24 /

-8.31 (-26.34%)

HCA HCA Healthcare
$166.48 /

-6.04 (-3.50%)

ENTA Enanta
$51.26 /

-1.54 (-2.92%)

DASH DoorDash
$69.19 /

-5.7 (-7.61%)

CWK Cushman & Wakefield
$14.84 /

-0.91 (-5.78%)

COIN Coinbase
$51.76 /

-3.625 (-6.55%)

ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

$ECON Economic Data
/

+

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

07/06/22 Baird
Baird says Amazon deal with Just Eat an efficient way to re-enter local delivery
06/29/22 JPMorgan
Amazon.com price target lowered to $175 from $200 at JPMorgan
06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/29/22 Redburn
Amazon.com initiated with a Buy at Redburn
TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

07/07/21 Bernstein
Just Eat Takeaway.com initiated with an Outperform at Bernstein
MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

07/06/22 Needham
RingCentral downgraded to Hold from Buy at Needham
06/27/22 William Blair
Okta not seeing backlash from security breach, says William Blair
06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

05/31/22 Benchmark
Marcus, Imax, WWE added to entertainment top ideas list at Benchmark
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
04/25/22 Benchmark
Activision results for Blizzard 'somewhat shocking,' says Benchmark
04/19/22 Goldman Sachs
Activision Blizzard assumed with Not Rated at Goldman Sachs
MO Altria Group
$41.09 /

-0.625 (-1.50%)

07/01/22 Deutsche Bank
Altria Group price target lowered to $46 from $60 at Deutsche Bank
06/29/22 Barclays
Altria Group downgraded to Underweight from Equal Weight at Barclays
06/27/22 Cowen
Altria Group price target lowered to $45 from $56 at Cowen
06/24/22 Morgan Stanley
Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
RFP Resolute Forest
$20.34 /

+7.85 (+62.85%)

06/23/22 TD Securities
Resolute Forest price target lowered to $16 from $17.50 at TD Securities
01/10/22 CIBC
Resolute Forest upgraded to Outperformer from Neutral at CIBC
10/21/21
Fly Intel: Top five analyst downgrades
10/21/21 CIBC
Resolute Forest downgraded to Neutral from Outperformer at CIBC
$ECON Economic Data
/

+

07/01/22 JPMorgan
JPMorgan forecast 'perilously close' to recession after GDP cuts
05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
02/18/22 Stifel
Stifel says S&P 500 correction in Q1 isn't over
11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
SPX S&P 500
/

+

06/27/22 Citi
Citi cuts S&P 500 year-end target, sees positive second half setup
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
SPY SPDR S&P 500 ETF Trust
$382.99 /

+1.02 (+0.27%)

RKT Rocket Companies
$8.38 /

+0.32 (+3.97%)

07/06/22 Wells Fargo
Wells Fargo upgrades Rocket Companies to Overweight, raises price target to $10
07/06/22 Wells Fargo
Rocket Companies upgraded to Overweight from Equal Weight at Wells Fargo
06/17/22 Wells Fargo
Rocket Companies price target lowered to $6.50 from $8.00 at Wells Fargo
05/31/22 Argus
Rocket Companies cut to Hold at Argus on 'significantly higher' mortgage rates
RNG RingCentral
$55.37 /

-5.86 (-9.57%)

05/23/22 Jefferies
RingCentral price target lowered to $80 from $100 at Jefferies
05/18/22 Wells Fargo
RingCentral price target lowered to $115 from $150 at Wells Fargo
05/16/22 Baird
Baird downgrades three cloud stocks on focus shift to cash flows
COIN Coinbase
$51.76 /

-3.625 (-6.55%)

07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
07/06/22 Atlantic Equities
Coinbase downgraded to Neutral from Overweight at Atlantic Equities
06/27/22 Goldman Sachs
Coinbase downgraded to Sell from Neutral at Goldman Sachs
06/23/22 Redburn
Coinbase downgraded to Neutral from Buy at Redburn
ENTA Enanta
$51.26 /

-1.54 (-2.92%)

07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
07/01/22 RBC Capital
Enanta price target raised to $67 from $64 at RBC Capital
06/22/22 Piper Sandler
Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler
UHS Universal Health
$102.27 /

-2.59 (-2.47%)

07/06/22 BMO Capital
Universal Health downgraded to Underperform from Market Perform at BMO Capital
07/06/22 BMO Capital
Universal Health downgraded to Underperform from Market Perform at BMO Capital
07/01/22 Mizuho
Universal Health price target lowered to $121 from $153 at Mizuho
06/16/22 Loop Capital
Loop starts Universal Health at Hold on behavioral health staffing concerns
HCA HCA Healthcare
$166.48 /

-6.04 (-3.50%)

07/06/22 BMO Capital
HCA Healthcare downgraded to Underperform from Market Perform at BMO Capital
07/06/22 BMO Capital
HCA Healthcare downgraded to Underperform from Market Perform at BMO Capital
07/01/22 Mizuho
HCA Healthcare price target lowered to $210 from $260 at Mizuho
06/21/22 RBC Capital
HCA Healthcare price target lowered to $256 from $267 at RBC Capital
MAR Marriott
$135.50 /

-3.21 (-2.31%)

06/28/22 Barclays
Marriott initiated with an Overweight at Barclays
05/04/22 Stifel
Marriott price target raised to $180 from $175 at Stifel
02/16/22 Truist
Marriott price target raised to $182 from $156 at Truist
02/16/22 Deutsche Bank
Marriott price target raised to $164 from $150 at Deutsche Bank
VIVHY Vivendi
$9.47 /

-0.06 (-0.63%)

04/26/22 Credit Suisse
Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse
04/25/22 JPMorgan
Vivendi price target raised to EUR 13.60 from EUR 13.30 at JPMorgan
04/11/22 Credit Suisse
Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse
03/16/22 Deutsche Bank
Vivendi price target lowered to EUR 14 from EUR 15 at Deutsche Bank
LGF.A Lionsgate
$8.35 /

-0.365 (-4.19%)

06/03/22 Deutsche Bank
Lionsgate price target lowered to $13 from $16 at Deutsche Bank
06/02/22 Wolfe Research
Lionsgate initiated with an Outperform at Wolfe Research
04/19/22 Rosenblatt
Lionsgate initiated with a Buy at Rosenblatt
02/07/22 Cowen
Lionsgate price target lowered to $17 from $21 at Cowen
LGF.B Lionsgate
$7.93 /

-0.295 (-3.59%)

01/31/22 Truist
Lionsgate price target raised to $18 from $16 at Truist
01/04/22 Wells Fargo
Wells Fargo upgrades Lionsgate to Overweight, raises price target to $25
CWK Cushman & Wakefield
$14.84 /

-0.91 (-5.78%)

04/21/22 Citi
Cushman & Wakefield price target lowered to $21 from $23 at Citi
04/05/22 Goldman Sachs
Cushman & Wakefield initiated with a Buy at Goldman Sachs
03/10/22 Wolfe Research
Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research
12/01/21 Morgan Stanley
Cushman & Wakefield price target raised to $23.75 from $21.75 at Morgan Stanley
PINC Premier
$37.00 /

+1.21 (+3.38%)

05/04/22 Canaccord
Premier price target lowered to $44 from $47 at Canaccord
05/04/22 Piper Sandler
Premier upgraded to Overweight from Neutral at Piper Sandler
04/13/22 Guggenheim
Premier initiated with a Neutral at Guggenheim
03/31/22 Credit Suisse
Premier assumed with an Underperform at Credit Suisse
PTON Peloton
$10.14 /

-0.27 (-2.59%)

06/29/22 JPMorgan
Peloton price target lowered to $20 from $24 at JPMorgan
06/28/22 Stifel
Peloton price target lowered to $13 from $14 at Stifel
06/17/22 Evercore ISI
Peloton price target lowered to $14 from $20 at Evercore ISI
06/07/22 Citi
Peloton CFO well positioned to manage subscriber growth, says Citi
VERU Veru
$13.02 /

+1.51 (+13.12%)

07/06/22 Jefferies
Veru data likely portend FDA authorization in 30 days, says Jefferies
05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

07/06/22 RBC Capital
Rivian Automotive's Q2 deliveries stronger than expected, says RBC Capital
07/06/22 Baird
Rivian Q2 production update a 'step in the right direction,' says Baird
06/30/22 RBC Capital
RBC confident in Rivian Automotive achieving Q2 delivery estimates
06/27/22 Mizuho
Rivian Automotive price target lowered to $70 from $80 at Mizuho
TLRY Tilray
$3.49 /

+0.265 (+8.22%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/16/22 Canaccord
Hexo downgraded to Hold at Canaccord on faltering turnaround prospects
06/15/22 Alliance Global Partners
Hexo downgraded to Neutral from Buy at Alliance Global Partners
06/15/22 Canaccord
Tilray price target lowered to $7 from $9 at CanaccordHexo
WISH ContextLogic
$1.63 /

-0.15 (-8.45%)

03/22/22 Loop Capital
ContextLogic cut to Hold at Loop Capital on inflation and and European exposure
03/22/22 Loop Capital
ContextLogic downgraded to Hold from Buy at Loop Capital
12/02/21
Fly Intel: Top five analyst downgrades
12/02/21 UBS
ContextLogic assumed with Neutral from Buy at UBS
DASH DoorDash
$69.19 /

-5.7 (-7.61%)

07/07/22 Citi
DoorDash price target lowered to $118 from $138 at Citi
06/29/22 JPMorgan
DoorDash price target lowered to $90 from $100 at JPMorgan
06/27/22 Needham
DoorDash price target lowered to $100 from $140 at Needham
06/21/22 Goldman Sachs
DoorDash reinstated with a Neutral at Goldman Sachs
UBER Uber
$21.44 /

-1.09 (-4.84%)

06/29/22 JPMorgan
Uber price target lowered to $48 from $60 at JPMorgan
06/29/22 Wedbush
Uber assumed with an Outperform at Wedbush
06/24/22 Wolfe Research
Uber price target lowered to $27 from $30 at Wolfe Research
06/16/22 Mizuho
Uber hits 'speed bump' in Massachusetts, says Mizuho
KRNT Kornit Digital
$23.24 /

-8.31 (-26.34%)

07/06/22 Craig-Hallum
Craig-Hallum downgrades Kornit Digital to Hold, lowers price target to $26
07/06/22 Needham
Kornit Digital price target lowered to $38 from $75 at Needham
07/06/22 Craig-Hallum
Kornit Digital downgraded to Hold from Buy at Craig-Hallum
07/06/22 Citi
Kornit Digital price target lowered to $50 from $90 at Citi
RADA Rada Electronic
$7.70 /

-1.33 (-14.73%)

05/10/22 Alliance Global Partners
Rada Electronic price target lowered to $13 from $14 at Alliance Global
04/19/22 Canaccord
Rada Electronic price target raised to $19 from $14
03/17/22 Alliance Global Partners
Rada Electronic downgraded to Neutral from Buy at Alliance Global Partners
01/12/22 Canaccord
Rada Electronic price target lowered to $14 from $16 at Canaccord
TTOO T2 Biosystems
/

+

02/18/22 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
02/18/22 Canaccord
T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord
01/18/22 Canaccord
T2 Biosystems significantly undervalued at current levels, say Canaccord
ARTW Art's Way
$2.35 /

-0.46 (-16.37%)

SFET Safe-T
/

+

01/31/22
Safe-T initiated with a Buy at Dawson James
09/23/21 Alliance Global Partners
Safe-T initiated with a Buy at Alliance Global Partners
WISH ContextLogic
$1.63 /

-0.15 (-8.45%)

VERU Veru
$13.02 /

+1.51 (+13.12%)

UHS Universal Health
$102.27 /

-2.59 (-2.47%)

UBER Uber
$21.44 /

-1.09 (-4.84%)

TTOO T2 Biosystems
/

+

TLRY Tilray
$3.49 /

+0.265 (+8.22%)

SFET Safe-T
/

+

RNG RingCentral
$55.37 /

-5.86 (-9.57%)

RKT Rocket Companies
$8.38 /

+0.32 (+3.97%)

RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

RFP Resolute Forest
$20.34 /

+7.85 (+62.85%)

RADA Rada Electronic
$7.70 /

-1.33 (-14.73%)

PTON Peloton
$10.14 /

-0.27 (-2.59%)

PINC Premier
$37.00 /

+1.21 (+3.38%)

MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

MO Altria Group
$41.09 /

-0.625 (-1.50%)

MAR Marriott
$135.50 /

-3.21 (-2.31%)

LGF.A Lionsgate
$8.35 /

-0.365 (-4.19%)

KRNT Kornit Digital
$23.24 /

-8.31 (-26.34%)

HCA HCA Healthcare
$166.48 /

-6.04 (-3.50%)

ENTA Enanta
$51.26 /

-1.54 (-2.92%)

DASH DoorDash
$69.19 /

-5.7 (-7.61%)

CWK Cushman & Wakefield
$14.84 /

-0.91 (-5.78%)

COIN Coinbase
$51.76 /

-3.625 (-6.55%)

ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

ARTW Art's Way
$2.35 /

-0.46 (-16.37%)

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

$ECON Economic Data
/

+

  • 19
    Nov
  • 16
    Nov
  • 10
    Nov
  • 19
    Aug
  • 12
    Aug
  • 29
    Jul
VIVHY Vivendi
$9.47 /

-0.06 (-0.63%)

VERU Veru
$13.02 /

+1.51 (+13.12%)

UHS Universal Health
$102.27 /

-2.59 (-2.47%)

UBER Uber
$21.44 /

-1.09 (-4.84%)

TLRY Tilray
$3.49 /

+0.265 (+8.22%)

RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

PTON Peloton
$10.14 /

-0.27 (-2.59%)

PINC Premier
$37.00 /

+1.21 (+3.38%)

MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

MO Altria Group
$41.09 /

-0.625 (-1.50%)

MAR Marriott
$135.50 /

-3.21 (-2.31%)

LGF.B Lionsgate
$7.93 /

-0.295 (-3.59%)

LGF.A Lionsgate
$8.35 /

-0.365 (-4.19%)

HCA HCA Healthcare
$166.48 /

-6.04 (-3.50%)

DASH DoorDash
$69.19 /

-5.7 (-7.61%)

CWK Cushman & Wakefield
$14.84 /

-0.91 (-5.78%)

COIN Coinbase
$51.76 /

-3.625 (-6.55%)

ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

$ECON Economic Data
/

+

WISH ContextLogic
$1.63 /

-0.15 (-8.45%)

VIVHY Vivendi
$9.47 /

-0.06 (-0.63%)

VERU Veru
$13.02 /

+1.51 (+13.12%)

UHS Universal Health
$102.27 /

-2.59 (-2.47%)

UBER Uber
$21.44 /

-1.09 (-4.84%)

TLRY Tilray
$3.49 /

+0.265 (+8.22%)

SFET Safe-T
/

+

RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

RADA Rada Electronic
$7.70 /

-1.33 (-14.73%)

PTON Peloton
$10.14 /

-0.27 (-2.59%)

MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

MO Altria Group
$41.09 /

-0.625 (-1.50%)

MAR Marriott
$135.50 /

-3.21 (-2.31%)

LGF.A Lionsgate
$8.35 /

-0.365 (-4.19%)

HCA HCA Healthcare
$166.48 /

-6.04 (-3.50%)

ENTA Enanta
$51.26 /

-1.54 (-2.92%)

DASH DoorDash
$69.19 /

-5.7 (-7.61%)

COIN Coinbase
$51.76 /

-3.625 (-6.55%)

ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

$ECON Economic Data
/

+

WISH ContextLogic
$1.63 /

-0.15 (-8.45%)

VERU Veru
$13.02 /

+1.51 (+13.12%)

UHS Universal Health
$102.27 /

-2.59 (-2.47%)

UBER Uber
$21.44 /

-1.09 (-4.84%)

TLRY Tilray
$3.49 /

+0.265 (+8.22%)

SPX S&P 500
/

+

RNG RingCentral
$55.37 /

-5.86 (-9.57%)

RKT Rocket Companies
$8.38 /

+0.32 (+3.97%)

RIVN Rivian Automotive
$29.61 /

+2.74 (+10.20%)

PTON Peloton
$10.14 /

-0.27 (-2.59%)

MSFT Microsoft
$265.97 /

+3.1 (+1.18%)

MO Altria Group
$41.09 /

-0.625 (-1.50%)

MAR Marriott
$135.50 /

-3.21 (-2.31%)

DASH DoorDash
$69.19 /

-5.7 (-7.61%)

COIN Coinbase
$51.76 /

-3.625 (-6.55%)

ATVI Activision Blizzard
$78.32 /

-0.505 (-0.64%)

AMZN Amazon.com
$114.19 /

+0.635 (+0.56%)

SPY SPDR S&P 500 ETF Trust
$382.99 /

+1.02 (+0.27%)

SPX S&P 500
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.